A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification

European Journal of Cancer

Volumn 49, Issue 9, 2013, Pages 2152-2160

  Xia, Wei Xiong ^a   Zhang, Hai Bo ^a   Shi, Jun Li ^a   Lu, Xing ^a   Wang, Lin ^a   Ye, Yan Fang ^a   Cao, Ka Jia ^a   Qian, Chao Nan ^a   Guo, Xiang ^a   Xiang, Yan Qun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

C reactive protein; Distant metastasis; Nasopharyngeal carcinoma; Prognosis; Survival

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; GLOBULIN; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); DEATH; DIAGNOSTIC PROCEDURE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARAMETERS; PRIORITY JOURNAL; RISK ASSESSMENT; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; L-LACTATE DEHYDROGENASE; LEUKOCYTES; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEUTROPHILS; PROGNOSIS; ROC CURVE; SERUM ALBUMIN; SERUM GLOBULINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84877708436     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.03.003     Document Type: Article

References (40)

1. M. Adham, A.N. Kurniawan, and A.I. Muhtadi Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation Chin J Cancer 31 4 2012 185 196
2. S.M. Cao, M.J. Simons, and C.N. Qian The prevalence and prevention of nasopharyngeal carcinoma in China Chin J Cancer 30 2 2011 114 119
3. J.T. Wee, T.C. Ha, S.L. Loong, and C.N. Qian Is nasopharyngeal cancer really a "Cantonese cancer"? Chin J Cancer 29 5 2010 517 526
4. W.I. Wei, and J.S. Sham Nasopharyngeal carcinoma Lancet 365 9476 2005 2041 2054
5. A.W. Lee, W.T. Ng, and L.K. Chan The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement Oral Oncol 48 10 2012 1007 1013
6. A.W. Lee, W.H. Lau, and S.Y. Tung Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group J Clin Oncol 23 28 2005 6966 6975
7. D. Kwong, J. Sham, and D. Choy The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients Int J Radiat Oncol Biol Phys 30 5 1994 1029 1036
8. S.L. Wolden, W.C. Chen, D.G. Pfister, D.H. Kraus, S.L. Berry, and M.J. Zelefsky Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience Int J Radiat Oncol Biol Phys 64 1 2006 57 62
9. J.A. Ludwig, and J.N. Weinstein Biomarkers in cancer staging, prognosis and treatment selection Nat Rev Cancer 5 11 2005 845 856
10. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 7 2009 1073 1081
11. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 1 2000 57 70
12. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
13. A.C. Chiang, and J. Massague Molecular basis of metastasis N Engl J Med 359 26 2008 2814 2823
14. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 6 2010 883 899
15. E. Espinosa, J. Feliu, and P. Zamora Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer Lung Cancer 12 1-2 1995 67 76
16. A. Shankar, J.J. Wang, E. Rochtchina, M.C. Yu, R. Kefford, and P. Mitchell Association between circulating white blood cell count and cancer mortality: a population-based cohort study Arch Intern Med 166 2 2006 188 194
17. T. Yamanaka, S. Matsumoto, S. Teramukai, R. Ishiwata, Y. Nagai, and M. Fukushima The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer Oncology 73 3-4 2007 215 220
18. D.T. Alexandrescu, and P.H. Wiernik Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia Med Oncol 25 3 2008 309 314
19. T.K. Eigentler, A. Figl, and D. Krex Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma Cancer 117 8 2011 1697 1703
20. K.H. Allin, and B.G. Nordestgaard Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer Crit Rev Clin Lab Sci 48 4 2011 155 170
21. J.R. He, G.P. Shen, and Z.F. Ren Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma Head Neck 34 12 2012 1769 1776
22. P.Y. Chang, Y.B. Kuo, and T.L. Wu Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer Clin Chem Lab Med 2012 1 10
23. H.H. Chen, I.H. Chen, C.T. Liao, F.C. Wei, L.Y. Lee, and S.F. Huang Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study Clin Otolaryngol 36 2 2011 147 153
24. S.F. Huang, F.C. Wei, and C.T. Liao Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels Ann Surg Oncol 19 12 2012 3856 3864
25. S.D. Khandavilli, P.O. Ceallaigh, C.J. Lloyd, and R. Whitaker Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma Oral Oncol 45 10 2009 912 914
26. A.L. Kruse, H.T. Luebbers, and K.W. Gratz C-reactive protein levels: a prognostic marker for patients with head and neck cancer? Head Neck Oncol 2 2010 21
27. Y.C. Zeng, M. Xue, and F. Chi C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy Tumour Biol 33 3 2012 891 895
28. L.A. Hefler, N. Concin, and G. Hofstetter Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer Clin Cancer Res 14 3 2008 710 714
29. K.H. Allin, B.G. Nordestgaard, H. Flyger, and S.E. Bojesen Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study Breast Cancer Res 13 3 2011 R55
30. A.G. Eliopoulos, M. Stack, and C.W. Dawson Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors Oncogene 14 24 1997 2899 2916
31. T.V. Johnson, A. Abbasi, and A. Owen-Smith Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma J Urol 183 2 2010 480 485
32. M. Ishizuka, H. Nagata, K. Takagi, and K. Kubota Systemic inflammatory response associated with distant metastasis of T1 or T2 colorectal cancer Dig Dis Sci 55 11 2010 3181 3187
33. A.M. Al Murri, J.M. Bartlett, P.A. Canney, J.C. Doughty, C. Wilson, and D.C. McMillan Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer Br J Cancer 94 2 2006 227 230
34. L.M. Forrest, D.C. McMillan, C.S. McArdle, W.J. Angerson, K. Dagg, and H.R. Scott A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer Br J Cancer 92 10 2005 1834 1836
35. M. Shimoda, M. Katoh, J. Kita, T. Sawada, and K. Kubota The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer Chemotherapy 56 6 2010 501 506
36. A.B. Crumley, D.C. McMillan, M. McKernan, A.C. McDonald, and R.C. Stuart Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer Br J Cancer 94 5 2006 637 641
37. R. Sharma, J. Hook, M. Kumar, and H. Gabra Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer Eur J Cancer 44 2 2008 251 256
38. G.W. Lamb, M. Aitchison, S. Ramsey, S.L. Housley, and D.C. McMillan Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems Br J Cancer 106 2 2012 279 283
39. Y. Iimura, K. Saito, and Y. Fujii Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score J Urol 181 3 2009 1004 1012 discussion 1012
40. G. Gakis, T. Todenhofer, and M. Renninger Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score BJU Int 108 11 2011 1800 1805